Recombinant Anti-PDGFR1 x Anti-VEGF Bispecific Antibody (Diabody-CH3) (BSDBC-186)

Recombinant Anti-PDGFR1 x Anti-VEGF Bispecific Antibody (Diabody-CH3) is a fusion protein of two diabodies connected together by a CH3 region. In a diabody, the two scFvs with short linkers are from anti-PDGFR1 and anti-VEGF antibodies. The VH and VL domains form an inter-chain pairing. The diabody with different specificities is fused to each of the CH3 chains, which results in 2+2 antigen-binding valency and extends the half-life of this BsAb. This BsAb can bind two antigens simultaneously. It is designed for the research of Neovascular ocular disorders; Cancers therapy.

Datasheet INQUIRY

Specifications

Targets

PDGFR1 & VEGF

Type

Constant Domain-extended Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Neovascular ocular disorders; Cancers

Targets

Target 1

PDGFR1

Gene ID

5159

UniProt ID

P09619

Alternative Names

IMF1; KOGS; IBGC4; JTK12; PDGFR; PENTT; CD140B; PDGFR1; PDGFR-1; PDGFRβ; platelet-derived growth factor receptor beta; PDGFRB

Target 2

VEGF

Gene ID

7422

UniProt ID

P15692

Alternative Names

VEGFA; vascular endothelial growth factor A; VPF; VEGF; MVCD1; vascular permeability factor

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-PDGFR1 x Anti-VEGF Bispecific Antibody (Diabody-CH3) (BSDBC-186). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-PDGFR1 x Anti-VEGF Bispecific Antibody (Diabody-CH3) (CAT#: BSDBC-186)

Specifications

Targets

Customer Reviews and Q&As